Press Releases
Documents concerning new issue of shares
The documents below can now be find on our website
Full terms and conditions for the issuance of shares
The Board's opinion on significant events and set-off
Auditor's opinion on significant events and set-off
The documents are all in Swedish
For more information, contact
Berit Lindholm, CEO Bluefish Pharmaceuticals
Tel. 46 8 519 116 00
Email: berit.lindholm@bluefishpharma.com
About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.